Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income (loss)	$ (3,941)	$ 7,642
Adjustments to reconcile loss to net cash used in operating activities:
Depreciation	6
Share based compensation expenses to employees and non-employees	1,318	171
Financial expenses related to convertible loans, warrants and leases	2,232	949
Change in fair value of convertible component in convertible loans	(890)	435
Gain on liquidation of subsidiary		(9,593)
Changes in assets and liabilities:
Increase in other accounts receivables	(70)	(7)
Increase (decrease) in accounts payables	(39)	(13)
Increase (decrease) in other accounts payables	10	100
Net cash used in operating activities	(1,374)	(316)
Cash flows from investing activities
Increase in restricted cash	(20)
Purchase of property and equipment	(7)
Net cash used in investing activities	(27)
Cash flows from financing activities:
Proceeds from convertible loans	530	725
Lease payments	(6)
Proceeds from issuance of shares to minority interests in subsidiary	1,406
Repayment of convertible loans	(74)
Net cash provided by financing activities	1,856	725
Increase in cash and cash equivalents	455	409
Cash and cash equivalents and restricted cash at the beginning of the year	411	2
Cash and cash equivalents at the end of the period	866	411
Cash paid for interest	74
Supplemental disclosures of non- cash flow information:
Conversion of convertible loans	830	277
Issuance of warrants	60	94
Right of use asset	$ 52